GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » iDNA Genomics Public Ltd (CYS:IDNA) » Definitions » Operating Income

iDNA Genomics Public (CYS:IDNA) Operating Income : € Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is iDNA Genomics Public Operating Income?

iDNA Genomics Public's Operating Income for the six months ended in . 20 was €0.00 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. iDNA Genomics Public's Operating Income for the six months ended in . 20 was €0.00 Mil. iDNA Genomics Public's Revenue for the six months ended in . 20 was €0.00 Mil. Therefore, iDNA Genomics Public's Operating Margin % for the quarter that ended in . 20 was %.

iDNA Genomics Public's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.


iDNA Genomics Public Operating Income Historical Data

The historical data trend for iDNA Genomics Public's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iDNA Genomics Public Operating Income Chart

iDNA Genomics Public Annual Data
Trend
Operating Income

iDNA Genomics Public Semi-Annual Data
Operating Income

iDNA Genomics Public Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Operating Income for the trailing twelve months (TTM) ended in . 20 was € Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iDNA Genomics Public  (CYS:IDNA) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

iDNA Genomics Public's annualized ROC % for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

iDNA Genomics Public's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

ROC (Joel Greenblatt) %(Q: . 20 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: . 20  Q: . 20
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=/( ( ( + max(, 0)) + ( + max(, 0)) )/ )
=/( ( + )/ )
=/
= %

where Working Capital is:

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. Operating Income is also linked to Operating Margin %:

iDNA Genomics Public's Operating Margin % for the quarter that ended in . 20 is calculated as:

Operating Margin %=Operating Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


iDNA Genomics Public Operating Income Related Terms

Thank you for viewing the detailed overview of iDNA Genomics Public's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


iDNA Genomics Public Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Evrota 25- 27, Kifissia, GRC, 145 64
iDNA Genomics Public Ltd is engaged in performing precision medicine and genetic analysis (DNA Tests). Its focus is on developing and providing Genetic Testing Analysis both in Medical and Direct-To-Consumer Genomics sectors, with research activity through cooperation with universities in Greece and abroad.

iDNA Genomics Public Headlines